VSTM

Verastem, Inc.

Approval Confirmed

AVMAPKI FAKZYNJA CO-PACK

KRAS mutant-type (mt) recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

432d ago May 1, 2025

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

Approval Confirmed

avutometinib capsules; defactinib tablets

adult patients with Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant-type (mt) recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

188d ago Dec 31, 2025

SEC 8-K verified 15h ago

Countdown card →

VSTM

Verastem, Inc.

Phase 1 AI-extracted

VS-7375

multiple KRAS G12D solid tumors

157d ago ~ Jan 31, 2026

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

Catalyst Confirmed

AVMAPKI FAKZYNJA CO-PACK

KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)

146d ago Feb 11, 2026

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

PDUFA AI-extracted

AVMAPKI FAKZYNJA CO-PACK

KRAS mutant-type (mt) recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

102d ago Mar 27, 2026

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

Phase 2 AI-extracted

VS-7375

KRAS G12D solid tumors

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

Phase 3 AI-extracted

VS-7375

advanced KRAS G12D solid tumors

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

AdCom AI-extracted

AVMAPKI FAKZYNJA CO-PACK

KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC)

Date TBD Date TBD

SEC 8-K verified 14h ago

Countdown card →

VSTM

Verastem, Inc.

CRL AI-extracted

VS-7375

advanced KRAS G12D solid tumors

Date TBD Date TBD

SEC 8-K verified 14h ago

Countdown card →